for the Period Ended 31 March 2025
| Balance sheet | |
| Additional notes | |
| Balance sheet notes |
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Called up share capital not paid: |
|
|
|
| Fixed assets | |||
| Intangible assets: |
|
|
|
| Tangible assets: |
|
|
|
| Investments: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
|
|
| Debtors: | 4 |
|
|
| Cash at bank and in hand: |
|
|
|
| Investments: | 5 |
|
|
| Total current assets: |
|
|
|
| Prepayments and accrued income: |
|
|
|
| Creditors: amounts falling due within one year: | 6 |
(
|
(
|
| Net current assets (liabilities): |
( |
( |
|
| Total assets less current liabilities: |
( |
( |
|
| Creditors: amounts falling due after more than one year: |
|
|
|
| Provision for liabilities: |
|
|
|
| Accruals and deferred income: |
|
|
|
| Total net assets (liabilities): |
( |
( |
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Share premium account: |
|
|
|
| Other reserves: |
|
|
|
| Profit and loss account: |
( |
( |
|
| Total Shareholders' funds: |
( |
( |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2025
Basis of measurement and preparation
Other accounting policies
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 March 2025
At 1 April 2024 (as previously stated) 5,301 Prior period adjustment 10,149 At 1 April 2024 (restated) 15,450 Additions - Disposals - At 31 March 2025 15,450 The investments at year end comprise minority holdings in Signfier Medical Technologies Ltd, Umbra Holding Limited and Voolt Technologies Limited. The carrying value of the investment in Voolt Technologies Limited has been restated from £1 to £10,150, being the Company's confirmed cost of subscription for shares acquired in December 2023 via Umbra Nominee Ltd as nominee holder. The investment was previously recorded at a nominal value in error. The correction has been treated as a prior period adjustment in accordance with Section 10 of FRS 102, with the corresponding increase recognised in amounts owed to the Director within creditors. The adjustment has no effect on the Company's reported profit or loss for either the current or prior period, as it reflects a reclassification between the carrying value of the investment and the corresponding funding creditor.
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other debtors |
|
|
| Total |
|
|
for the Period Ended 31 March 2025
Current asset investments comprise GBP 275,000 nominal of 12% Secured Notes issued by Hybrid Advice Ltd (incorporated in Jersey, registration number 151793), acquired by the Company on 25 February 2025. The Notes are secured, bear interest at 12% per annum, and are repayable in accordance with the terms of the instrument constituting the Notes. They are classified as a current asset investment on the basis that repayment was expected within twelve months of the reporting date, consistent with their actual repayment in full in January 2026, subsequent to the year end.
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Bank loans and overdrafts |
|
|
| Other creditors |
|
|
| Total |
|
|
for the Period Ended 31 March 2025